Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syntermed is a medical imaging software company specializing in nuclear medicine and cardiology. The company is best known for the Emory Cardiac Toolbox (ECTb), a widely used software suite for the analysis and interpretation of cardiac positron emission tomography (PET) and single-photon emission computed tomography (SPECT) images. Their products provide clinicians with automated tools for quantifying myocardial perfusion, function, and viability, aiding in the diagnosis of coronary artery disease and heart failure. Beyond cardiology, Syntermed offers NeuroQ, a software tool for the assessment of brain PET scans to assist in diagnosing dementia and epilepsy. The company's solutions are integrated into various imaging hardware platforms globally, serving as a standard in clinical nuclear cardiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syntermed.